Alpha Tau Medical Ltd
$13.23-$0.12 (-0.9%)
Alpha Tau Medical Ltd’s quoted price sits in the upper half of its reported 52-week range, 16.21% below the high.
TLV · BCUR.TA · ILA
Stock price, earnings
Quote as of Oct 12, 2025, 11:24 AM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
Erika B-Cure Laser Ltd’s quoted price sits in the lower half of its reported 52-week range, 44.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Erika B-Cure Laser Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Erika B-Cure Laser Ltd, established in Haifa, Israel in 2007, is a company dedicated to the full lifecycle of its B-Cure laser product line, from development and manufacturing to global marketing, sales, and distribution. Formerly known as Erica Carmel Ltd until its rebranding in January 2022, the company offers a diverse array of laser devices tailored for various therapeutic applications in both domestic and international markets. Their product portfolio includes: The B-Cure Laser Classic, a medical device for home use that addresses a broad spectrum of conditions including general pain, orthopedic issues, dermatological problems, inflammation, and supports wound healing. The B-Cure Laser Pro, designed to treat more severe or chronic ailments such as persistent orthopedic challenges, diabetic wounds, and difficulties in recovery, including mucositis. The B-Cure Laser Sport, a home-based device for managing sports injuries, athletic discomfort, and other orthopedic concerns. The professional-grade B-Cure Laser Sport Pro, which provides advanced treatment for sports-related injuries, pain relief in muscles and various body areas, and helps combat infections like Achilles tendonitis. For dental professionals, the B-Cure Laser Dental is an in-clinic device formulated to tackle a variety of oral health problems, alleviate gum pain and inflammation, expedite recovery post-dental procedures (including implants), and reduce associated swelling and discomfort. Additionally, the B-Pro Dental Laser Cure is available for dental clinics, specifically engineered to address diverse dental issues and infections.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$13.23-$0.12 (-0.9%)
Alpha Tau Medical Ltd’s quoted price sits in the upper half of its reported 52-week range, 16.21% below the high.
₪2.70+₪0.05 (+1.85%)
Almeda Ventures Limited Partnership’s quoted price sits in the upper half of its reported 52-week range, 12.05% below the high.
₪3.20₪0.00 (0.0%)
Endymed Ltd’s quoted price sits in the upper half of its reported 52-week range, 9.83% below the high.
₪0.43+₪0.01 (+1.65%)
Cannassure Therapeutics Ltd’s quoted price sits in the upper half of its reported 52-week range, 19.85% below the high.
₪0.30-₪0.02 (-5.45%)
Human Xtensions Ltd.’s quoted price sits in the upper half of its reported 52-week range, 44.02% below the high.
₪2.68-₪0.16 (-5.64%)
Erech Finance Cahalacha Ltd’s quoted price sits in the lower half of its reported 52-week range, 70.04% below the high.
₪0.47-₪0.02 (-4.08%)
Nextgen Biomed Ltd’s quoted price sits in the upper half of its reported 52-week range, 43.17% below the high.
₪0.90₪0.00 (0.0%)
Canzon Israel Ltd’s quoted price sits in the lower half of its reported 52-week range, 58.9% below the high.